EW
Edwards Lifesciences Corporation · $86.07 (-1.0%) · mkt cap $49.6B · P/E 51.2
21 hub catalysts across 6 sources · backtest → · ← Ticker Explorer
Analyst Ratings (Upgrades/Downgrades)FINRA Short VolumeInsider Transactions (SEC Form 4)Financial News (Google News)FDA Approvals & RecallsU.S. Senate — Congressional Trades
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
100▲ Bull-leanconviction from hub signals
Bullish factors
- Congress bought (1)
- FDA approval
- 3 analyst upgrades
Bearish factors
- Insiders net selling (12 vs 0)
Context (not directional): Short volume 1% of float-traded · News flow (3 recent)
Signal mix for EW
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeCCI Mean-Reversion has fit EW best over 2 years (+165.2%, Sharpe 2.16). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | CCI Mean-Reversion | +165.2% | 2.16 | ✓ |
| 2 | Bollinger Bands | +56.9% | 1.55 | ✓ |
| 3 | Stochastic Oscillator | +84.6% | 1.37 | ✓ |
Price — 1 year
daily closeInsider activity
0 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-07-28 | SELL | Markowitz Wayne | 9,628 | $819K |
| 2026-07-27 | SELL | Zovighian Bernard J | 2,920 | $245K |
| 2026-07-10 | SELL | Lippis Daniel J | 619 | $57K |
| 2026-06-30 | SELL | Lippis Daniel J | 619 | $57K |
| 2026-06-17 | SELL | Zovighian Bernard J | 523 | $46K |
| 2026-05-29 | SELL | Dahl Andrew M | 567 | $49K |
| 2026-05-27 | SELL | Bobo Donald E Jr | 23,145 | $2.0M |
| 2026-05-22 | SELL | Chopra Daveen | 1,500 | $127K |
| 2026-05-18 | SELL | Lippis Daniel J | 620 | $50K |
| 2026-05-15 | SELL | Bobo Donald E Jr | 17,968 | $1.5M |
| 2026-05-12 | SELL | Zovighian Bernard J | 36,351 | $2.8M |
| 2026-05-11 | SELL | Markowitz Wayne | 593 | $47K |
Analyst ratings
live · 3 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| 2026-01-09 | Upgrade | TD Cowen | Hold → Buy |
| 2025-12-18 | Upgrade | JP Morgan | Neutral → Overweight |
Catalyst timeline
21 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Edwards SAPIEN 3 Pulmonic Delivery System: 9630PL29 — Edwards Lifesciences, LLC | approval | source ↗ |
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Edwards Crimper: 9600CR — Edwards Lifesciences, LLC | approval | source ↗ |
| 2026-07-27 | Insider Transactions (SEC Form 4) | Insider SELL | Zovighian Bernard J sold 2,920 sh | $245K | source ↗ |
| 2026-07-27 | Financial News (Google News) | News | EW Stock Quote Price and Forecast - CNN | 8 | source ↗ |
| 2026-07-25 | Analyst Ratings (Upgrades/Downgrades) | Analyst Upgrade | Leerink Partners: Upgrade (Market Perform → Outperform) | source ↗ | |
| 2026-07-25 | Financial News (Google News) | News | Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium - Yahoo Finance | 4 | source ↗ |
| 2026-07-24 | FINRA Short Volume | Short Vol | EW | 54% short | source ↗ |
| 2026-07-10 | Insider Transactions (SEC Form 4) | Insider SELL | Lippis Daniel J sold 619 sh | $57K | source ↗ |
| 2026-06-30 | Insider Transactions (SEC Form 4) | Insider SELL | Lippis Daniel J sold 619 sh | $57K | source ↗ |
| 2026-06-22 | FDA Approvals & Recalls | FDA Approval | FDA approved Edwards SAPIEN 3 Transcatheter Pulmonary Valve (TPV) System — Edwards Lifesciences, LLC | approval | source ↗ |
| 2026-06-17 | Insider Transactions (SEC Form 4) | Insider SELL | Zovighian Bernard J sold 523 sh | $46K | source ↗ |
| 2026-06-16 | Financial News (Google News) | News | Edwards Lifesciences (EW) Stock Could Be 11% Undervalued on Its TAVR and EVOQUE Story - simplywall.st | 2 | source ↗ |
| 2026-05-29 | Insider Transactions (SEC Form 4) | Insider SELL | Dahl Andrew M sold 567 sh | $49K | source ↗ |
| 2026-05-27 | Insider Transactions (SEC Form 4) | Insider SELL | Bobo Donald E Jr sold 23,145 sh | $2.0M | source ↗ |
| 2026-05-22 | Insider Transactions (SEC Form 4) | Insider SELL | Chopra Daveen sold 1,500 sh | $127K | source ↗ |
| 2026-05-18 | Insider Transactions (SEC Form 4) | Insider SELL | Lippis Daniel J sold 620 sh | $50K | source ↗ |
| 2026-05-15 | Insider Transactions (SEC Form 4) | Insider SELL | Bobo Donald E Jr sold 17,968 sh | $1.5M | source ↗ |
| 2026-05-12 | Insider Transactions (SEC Form 4) | Insider SELL | Zovighian Bernard J sold 36,351 sh | $2.8M | source ↗ |
| 2026-05-11 | Insider Transactions (SEC Form 4) | Insider SELL | Markowitz Wayne sold 593 sh | $47K | source ↗ |
| 2026-03-27 | U.S. Senate — Congressional Trades | Congress BUY | Armstrong, Alan (Senator) | $1,001 - $15,000 | source ↗ |
| 2026-01-09 | Analyst Ratings (Upgrades/Downgrades) | Analyst Upgrade | TD Cowen: Upgrade (Hold → Buy) | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-07-29 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice